Aripiprazole in the treatment of posttraumatic stress disorder. An open-label trial

Revista Brasileira de Psiquiatria

Volumn 30, Issue 4, 2008, Pages 358-361

  Mello, Marcelo Feijo ^a,b   Costa, Mariana Cadrobbi Pupo ^a   Schoedl, Aline Ferri ^a   Fiks, Jose Paulo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Aripiprazole; Patients; Randomized controlled trial; Stress disorders, post traumatic; Treatment

Indexed keywords

ARIPIPRAZOLE;

ADULT; ANXIETY; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; MALE; MONOTHERAPY; NAUSEA; POSTTRAUMATIC STRESS DISORDER; RATING SCALE; RESTLESSNESS; SHORT FORM 36; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 58549112958     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462008000400011     Document Type: Article

References (15)

1. Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC, Eaves LJ. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry. 1995;152(6):833-42.
2. Davidson JR. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J Clin Psychiatry. 2006;67(Suppl 2):34-9.
3. Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006;26(3):259-67.
4. Davidson JR, Weisler RH, Butterfield MI, Casat CD, Connor KM, Barnett S, van Meter S. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003;53(2):188-91.
5. Davidson J, Lipschitz A, Musgnung J. Treatment of PTSD with venlafaxine XR, sertraline, or placebo: a double-blind comparison. Int J Neuropsychopharmacol. 2004;7(Suppl 1):S364-5.
6. Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry. 2002;63(1):15-20.
7. Brady K,Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farferl GM. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283(14):1837-44.
8. Bartzokis G, Lu PH, Turner J, Mintz J, Saunders CS. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry. 2005;57(5):474-9.
9. Kozaric-Kovacic D, Pivac N. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features. Int J Neuropsychopharmacol. 2007;10(2):253-61.
10. Campbell ML, Morrison AP. The psychological consequences of combat exposure: the importance of appraisals and post-traumatic stress disorder symptomatology in the occurrence of delusional-like ideas. Br J Clin Psychol. 2007;46(Pt 2):187-201.
11. Villarreal G, Calais LA, Cañive JM, Lundy SL, Pickard J, Toney G. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. Psychopharmacol Bull. 2007;40(2):6-18.
12. Ruiz JE, Barbosa Neto J, Schoedl AF, Mello MF. Psychoneuroendocrinology of posttraumatic stress disorder. Rev Bras Psiquiatr. 2007;29(Suppl 1):S7-12.
13. Hirose T, Uwahodo Y, Yamada S, Miwa T, Kikuchi T, Kitagawa H, Burris KD, Altar CA, Nabeshima T. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. J Psychopharmacol. 2004;18(3):375-83.
14. Lambert MT. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans. Int Clin Psychopharmacol. 2006;21(3):185-7.
15. Padala PR, List D, Petty F, Bhatia SC. Adjunctive aripiprazole in combat-related posttraumatic stress disorder. Ann Pharmacother. 2007;41(10):1744.